says Nicholas D. James, MBBS, PhD. Adding the medication abiraterone acetate (Zytiga) plus prednisolone/prednisone to standard treatment (androgendeprivation therapy, ADT) lowers the risk for death by 37%. Abiraterone already is used to treat some men whose disease has spread, but the new findings mean that more men could benefit by using abiraterone with ADT as soon as they are diagnosed.
Nicholas D. James, MBBS, PhD, is honorary professor of clinical oncology at Institute of Cancer and Genomic Sciences, University of Birmingham, UK. Bottom Line Personal 8-2017
IF YOU LIKE THESE POSTS, PLEASE CONSIDERING CLICKING THE DONATION BUTTON ABOVE THANK YOU!